ECP, a cytotoxic protein predominantly released by eosinophils, has gained attention in the context of schizophrenia due to its potential involvement in neuroinflammatory processes within the CNS.[13] ECP, known for its antimicrobial properties and modulatory effects on immune responses, has been explored in various inflammatory conditions and is emerging as a putative contributor to neuroinflammation in schizophrenia. Here, RNASE3 is linked to schizophrenia.